Chung Wu Investment Group »

Bridgebio Pharma shares owned by Chung Wu Investment Group

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Chung Wu Investment Group from 13F filings

Historical chart of Chung Wu Investment Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Chung Wu Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Chung Wu Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $23k 300 76.49

More positions owned by Chung Wu Investment Group

Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Spdr Dow Jones Industrial Average Etf Trust Ut Ser 1 (DIA)
Neos S&p 500 High Income Etf Neos S&p 500 Hi (SPYI)
Neos Nasdaq 100 High Income Etf Nasdaq 100 High (QQQI)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Unit (SPY)
Micron Technology (MU)
Antero Midstream Corp antero midstream (AM)
Abbvie (ABBV)
Goldman Sachs (GS)
Exxon Mobil Corporation (XOM)

View all positions for Chung Wu Investment Group

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma